Drugs for Neglected Diseases initiative (DNDi) / dndi_transparency-activities
Mycetoma
CH-FDJP-CHE110141200-11
EUR 7.20mdeclared budget
EUR 5.45mdisbursed and spent, 791 of 791 transactions
Implementationstatus
31 Dec 2028planned end
Budget over time
- Reporting organisation
- Drugs for Neglected Diseases initiative (DNDi)
- Start
- 01 Jan 2015 (planned)
- Countries
- —
- Sectors
- Health policy and administrative management (12110) 10%; Medical services (12191) 10%; Basic health infrastructure (12230) 10%; Infectious disease control (12250) 50%; Health education (12261) 5%; Health personnel development (12281) 15%; 121 · OECD DAC 3-digit 20%; 122 · OECD DAC 3-digit 80%; 3 · SDG goal 100%; 3.3 · SDG target 100%; 3.3.5 Number of people requiring interventions against neglected tropical diseases · SDG indicator 100%
- Funded by
- Drugs for Neglected Diseases initiative
- Participating
- Drugs for Neglected Diseases initiative (funding)
- Versions seen
- 2 since 26 Sept 2026 · last checked 2026-10-03 02:26 UTC
Changes
- 2026-10-03Budget changed+1 more
Budgets
| Period | Type | Value | Record |
|---|---|---|---|
| 2020-01-01 → 2020-12-31 | revised, indicative | EUR 776k | new since 02 Oct 2026 |
| 2019-01-01 → 2019-12-31 | revised, indicative | EUR 1.09m | new since 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | revised, indicative | EUR 870k | new since 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | revised, indicative | EUR 545k | new since 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | revised, indicative | EUR 651k | new since 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | revised, indicative | EUR 904k | new since 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | revised, indicative | EUR 1.17m | new since 02 Oct 2026 |
| 2025-01-01 → 2025-12-31 | revised, indicative | EUR 1.19m | new since 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | original | EUR 776k | superseded, last seen 02 Oct 2026 |
| 2019-01-01 → 2019-12-31 | original | EUR 1.09m | superseded, last seen 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | original | EUR 870k | superseded, last seen 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | original | EUR 545k | superseded, last seen 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | original | EUR 651k | superseded, last seen 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | original | EUR 904k | superseded, last seen 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | original | EUR 1.17m | superseded, last seen 02 Oct 2026 |
Transactions
| Date | Type | Value | To | Note | Record |
|---|---|---|---|---|---|
| 2020-10-31 | Expenditure | EUR 1,037 | Drugs for Neglected Diseases initiative | Expenses - 11-2010-1-CH-XM-DAC-7 | |
| 2020-10-31 | Expenditure | EUR 1,387 | Drugs for Neglected Diseases initiative | Expenses - 11-2010-2-CH-GB-GOV-1 | |
| 2020-10-31 | Expenditure | EUR 6,808 | Drugs for Neglected Diseases initiative | Expenses - 11-2010-1-KE-GB-GOV-1 | |
| 2020-10-31 | Expenditure | EUR 371 | Drugs for Neglected Diseases initiative | Expenses - 11-2010-2-KE | |
| 2020-10-31 | Expenditure | EUR 161 | Drugs for Neglected Diseases initiative | Expenses - 11-2010-1-MY-GB-GOV-1 | |
| 2020-10-31 | Expenditure | EUR 755 | Drugs for Neglected Diseases initiative | Expenses - 11-2010-1-US-GB-GOV-1 | |
| 2020-11-30 | Expenditure | EUR 6 | Drugs for Neglected Diseases initiative | Expenses - 11-2011-1-BR | |
| 2020-11-30 | Expenditure | EUR 1,089 | Drugs for Neglected Diseases initiative | Expenses - 11-2011-2-BR | |
| 2020-11-30 | Expenditure | EUR 2,858 | Drugs for Neglected Diseases initiative | Expenses - 11-2011-1-CH | |
| 2020-11-30 | Expenditure | EUR 55 | Drugs for Neglected Diseases initiative | Expenses - 11-2011-1-KE | |
| 2020-11-30 | Expenditure | EUR -55 | Drugs for Neglected Diseases initiative | Expenses - 11-2011-2-KE | |
| 2020-11-30 | Expenditure | EUR 9,207 | Drugs for Neglected Diseases initiative | Expenses - 11-2011-3-KE | |
| 2020-11-30 | Expenditure | EUR 55 | Drugs for Neglected Diseases initiative | Expenses - 11-2011-4-KE-GB-GOV-1 | |
| 2020-11-30 | Expenditure | EUR 84k | Drugs for Neglected Diseases initiative | Expenses - 11-2011-1-NL | |
| 2020-12-31 | Expenditure | EUR 734 | Drugs for Neglected Diseases initiative | Expenses - 11-2012-1-BR-GB-GOV-1 | |
| 2020-12-31 | Expenditure | EUR 833 | Drugs for Neglected Diseases initiative | Expenses - 11-2012-1-CH | |
| 2020-12-31 | Expenditure | EUR 357k | Drugs for Neglected Diseases initiative | Expenses - 11-2012-2-CH-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 2,578 | CH-FDJP-CHE110141200 | Expenses - 11-1801-1-CH-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 796 | CH-FDJP-CHE110141200 | Expenses - 11-1801-1-FR | |
| 2018-01-31 | Expenditure | EUR 7,467 | CH-FDJP-CHE110141200 | Expenses - 11-1801-1-KE | |
| 2018-01-31 | Expenditure | EUR 3,868 | CH-FDJP-CHE110141200 | Expenses - 11-1801-2-FR-GB-GOV-1 | |
| 2018-02-28 | Expenditure | EUR 714 | CH-FDJP-CHE110141200 | Expenses - 11-1802-1-CH | |
| 2018-02-28 | Expenditure | EUR 1,215 | CH-FDJP-CHE110141200 | Expenses - 11-1802-1-FR | |
| 2018-02-28 | Expenditure | EUR 8,999 | CH-FDJP-CHE110141200 | Expenses - 11-1802-1-FR-GB-GOV-1 | |
| 2018-02-28 | Expenditure | EUR 1,682 | CH-FDJP-CHE110141200 | Expenses - 11-1802-1-GB | |
| 2018-02-28 | Expenditure | EUR 7,448 | CH-FDJP-CHE110141200 | Expenses - 11-1802-1-KE | |
| 2018-02-28 | Expenditure | EUR 1,947 | CH-FDJP-CHE110141200 | Expenses - 11-1802-1-KE-GB-GOV-1 | |
| 2018-02-28 | Expenditure | EUR 6,910 | CH-FDJP-CHE110141200 | Expenses - 11-1802-1-NL | |
| 2018-03-31 | Expenditure | EUR 477 | CH-FDJP-CHE110141200 | Expenses - 11-1803-1-CH | |
| 2018-03-31 | Expenditure | EUR 491 | CH-FDJP-CHE110141200 | Expenses - 11-1803-1-FR | |
| 2018-03-31 | Expenditure | EUR 3,066 | CH-FDJP-CHE110141200 | Expenses - 11-1803-1-GB | |
| 2018-03-31 | Expenditure | EUR 22k | CH-FDJP-CHE110141200 | Expenses - 11-1803-1-KE | |
| 2018-03-31 | Expenditure | EUR 16k | CH-FDJP-CHE110141200 | Expenses - 11-1803-1-KE-GB-GOV-1 | |
| 2018-03-31 | Expenditure | EUR 314 | CH-FDJP-CHE110141200 | Expenses - 11-1803-1-NL | |
| 2018-03-31 | Expenditure | EUR 11k | CH-FDJP-CHE110141200 | Expenses - 11-1803-1-NL-GB-GOV-1 | |
| 2018-04-30 | Expenditure | EUR 1,162 | CH-FDJP-CHE110141200 | Expenses - 11-1804-1-BR | |
| 2018-04-30 | Expenditure | EUR 1,176 | CH-FDJP-CHE110141200 | Expenses - 11-1804-1-BR-CH-4 | |
| 2018-04-30 | Expenditure | EUR 607 | CH-FDJP-CHE110141200 | Expenses - 11-1804-1-CH | |
| 2018-04-30 | Expenditure | EUR 20k | CH-FDJP-CHE110141200 | Expenses - 11-1804-1-FR | |
| 2018-04-30 | Expenditure | EUR 631 | CH-FDJP-CHE110141200 | Expenses - 11-1804-1-GB | |
| 2018-04-30 | Expenditure | EUR 13k | CH-FDJP-CHE110141200 | Expenses - 11-1804-1-KE | |
| 2018-04-30 | Expenditure | EUR 10k | CH-FDJP-CHE110141200 | Expenses - 11-1804-1-NL | |
| 2018-05-31 | Expenditure | EUR 1,404 | CH-FDJP-CHE110141200 | Expenses - 11-1805-1-BR | |
| 2018-05-31 | Expenditure | EUR 356 | CH-FDJP-CHE110141200 | Expenses - 11-1805-1-BR-CH-4 | |
| 2018-05-31 | Expenditure | EUR 34k | CH-FDJP-CHE110141200 | Expenses - 11-1805-1-FR | |
| 2018-05-31 | Expenditure | EUR 1,863 | CH-FDJP-CHE110141200 | Expenses - 11-1805-1-GB | |
| 2018-05-31 | Expenditure | EUR 41k | CH-FDJP-CHE110141200 | Expenses - 11-1805-1-KE | |
| 2018-05-31 | Expenditure | EUR 8,162 | CH-FDJP-CHE110141200 | Expenses - 11-1805-1-NL | |
| 2018-06-30 | Expenditure | EUR 942 | CH-FDJP-CHE110141200 | Expenses - 11-1806-1-BR | |
| 2018-06-30 | Expenditure | EUR -364 | CH-FDJP-CHE110141200 | Expenses - 11-1806-1-BR-CH-4 | |
| 2018-06-30 | Expenditure | EUR 474 | CH-FDJP-CHE110141200 | Expenses - 11-1806-1-CH | |
| 2018-06-30 | Expenditure | EUR 38k | CH-FDJP-CHE110141200 | Expenses - 11-1806-1-FR | |
| 2018-10-31 | Expenditure | EUR 2,255 | CH-FDJP-CHE110141200 | Expenses - 11-1810-1-GB | |
| 2018-10-31 | Expenditure | EUR 22k | CH-FDJP-CHE110141200 | Expenses - 11-1810-1-KE | |
| 2018-10-31 | Expenditure | EUR 11k | CH-FDJP-CHE110141200 | Expenses - 11-1810-1-NL | |
| 2018-10-31 | Expenditure | EUR 4,079 | CH-FDJP-CHE110141200 | Expenses - 11-1810-1-UG | |
| 2018-10-31 | Expenditure | EUR 1,491 | CH-FDJP-CHE110141200 | Expenses - 11-1810-1-US | |
| 2018-11-30 | Expenditure | EUR 402 | CH-FDJP-CHE110141200 | Expenses - 11-1811-1-BR | |
| 2018-11-30 | Expenditure | EUR 42 | CH-FDJP-CHE110141200 | Expenses - 11-1811-1-BR-GB-GOV-1 | |
| 2018-11-30 | Expenditure | EUR 640 | CH-FDJP-CHE110141200 | Expenses - 11-1811-1-CH | |
| 2018-11-30 | Expenditure | EUR 3,167 | CH-FDJP-CHE110141200 | Expenses - 11-1811-1-FR | |
| 2018-11-30 | Expenditure | EUR 2,687 | CH-FDJP-CHE110141200 | Expenses - 11-1811-1-GB | |
| 2018-11-30 | Expenditure | EUR 18k | CH-FDJP-CHE110141200 | Expenses - 11-1811-1-KE | |
| 2018-11-30 | Expenditure | EUR 48k | CH-FDJP-CHE110141200 | Expenses - 11-1811-1-NL | |
| 2018-11-30 | Expenditure | EUR -260 | CH-FDJP-CHE110141200 | Expenses - 11-1811-1-US | |
| 2018-11-30 | Expenditure | EUR 14k | CH-FDJP-CHE110141200 | Expenses - 11-1811-2-NL-GB-GOV-1 | |
| 2018-12-31 | Expenditure | EUR 715 | CH-FDJP-CHE110141200 | Expenses - 11-1812-1-BR | |
| 2018-12-31 | Expenditure | EUR -336 | CH-FDJP-CHE110141200 | Expenses - 11-1812-1-BR-GB-GOV-1 | |
| 2018-12-31 | Expenditure | EUR 4,321 | CH-FDJP-CHE110141200 | Expenses - 11-1812-1-CH | |
| 2018-12-31 | Expenditure | EUR 65k | CH-FDJP-CHE110141200 | Expenses - 11-1812-1-FR | |
| 2018-12-31 | Expenditure | EUR 5,405 | CH-FDJP-CHE110141200 | Expenses - 11-1812-1-GB | |
| 2018-12-31 | Expenditure | EUR 61k | CH-FDJP-CHE110141200 | Expenses - 11-1812-1-KE | |
| 2018-12-31 | Expenditure | EUR 4,917 | CH-FDJP-CHE110141200 | Expenses - 11-1812-1-NL | |
| 2018-06-30 | Expenditure | EUR 2,895 | CH-FDJP-CHE110141200 | Expenses - 11-1806-1-GB | |
| 2018-06-30 | Expenditure | EUR 27k | CH-FDJP-CHE110141200 | Expenses - 11-1806-1-KE | |
| 2018-06-30 | Expenditure | EUR 4,681 | CH-FDJP-CHE110141200 | Expenses - 11-1806-1-NL | |
| 2018-07-31 | Expenditure | EUR 898 | CH-FDJP-CHE110141200 | Expenses - 11-1807-1-BR | |
| 2018-07-31 | Expenditure | EUR 91 | CH-FDJP-CHE110141200 | Expenses - 11-1807-1-BR-CH-4 | |
| 2018-07-31 | Expenditure | EUR 1,067 | CH-FDJP-CHE110141200 | Expenses - 11-1807-1-CH | |
| 2018-07-31 | Expenditure | EUR 1,516 | CH-FDJP-CHE110141200 | Expenses - 11-1807-1-GB | |
| 2018-07-31 | Expenditure | EUR 17k | CH-FDJP-CHE110141200 | Expenses - 11-1807-1-KE | |
| 2018-07-31 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 11-1807-1-NL | |
| 2018-08-31 | Expenditure | EUR 878 | CH-FDJP-CHE110141200 | Expenses - 11-1808-1-BR | |
| 2018-08-31 | Expenditure | EUR 114 | CH-FDJP-CHE110141200 | Expenses - 11-1808-1-BR-GB-GOV-1 | |
| 2018-08-31 | Expenditure | EUR 448 | CH-FDJP-CHE110141200 | Expenses - 11-1808-1-FR | |
| 2018-08-31 | Expenditure | EUR 715 | CH-FDJP-CHE110141200 | Expenses - 11-1808-1-GB | |
| 2018-08-31 | Expenditure | EUR 384 | CH-FDJP-CHE110141200 | Expenses - 11-1808-1-JP | |
| 2018-08-31 | Expenditure | EUR 16k | CH-FDJP-CHE110141200 | Expenses - 11-1808-1-KE | |
| 2018-08-31 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 11-1808-1-NL | |
| 2018-08-31 | Expenditure | EUR 1,906 | CH-FDJP-CHE110141200 | Expenses - 11-1808-1-US | |
| 2018-09-30 | Expenditure | EUR 578 | CH-FDJP-CHE110141200 | Expenses - 11-1809-1-BR | |
| 2018-09-30 | Expenditure | EUR -388 | CH-FDJP-CHE110141200 | Expenses - 11-1809-1-BR-GB-GOV-1 | |
| 2018-09-30 | Expenditure | EUR 320 | CH-FDJP-CHE110141200 | Expenses - 11-1809-1-CH | |
| 2018-09-30 | Expenditure | EUR 2,811 | CH-FDJP-CHE110141200 | Expenses - 11-1809-1-FR | |
| 2018-09-30 | Expenditure | EUR 1,450 | CH-FDJP-CHE110141200 | Expenses - 11-1809-1-GB | |
| 2019-01-31 | Expenditure | EUR 342 | CH-FDJP-CHE110141200 | Expenses - 11-1901-1-BR | |
| 2019-01-31 | Expenditure | EUR -439 | CH-FDJP-CHE110141200 | Expenses - 11-1901-1-BR-GB-GOV-1 | |
| 2019-01-31 | Expenditure | EUR 1,780 | CH-FDJP-CHE110141200 | Expenses - 11-1901-1-CH | |
| 2019-01-31 | Expenditure | EUR 2,928 | CH-FDJP-CHE110141200 | Expenses - 11-1901-1-CH-GB-GOV-1 | |
| 2019-01-31 | Expenditure | EUR 1,849 | CH-FDJP-CHE110141200 | Expenses - 11-1901-1-FR | |
| 2019-01-31 | Expenditure | EUR 15k | CH-FDJP-CHE110141200 | Expenses - 11-1901-1-KE | |
| 2019-01-31 | Expenditure | EUR 1,247 | CH-FDJP-CHE110141200 | Expenses - 11-1901-1-KE-GB-GOV-1 | |
| 2019-01-31 | Expenditure | EUR 2,001 | CH-FDJP-CHE110141200 | Expenses - 11-1901-2-KE-GB-GOV-1 | |
| 2018-09-30 | Expenditure | EUR 26k | CH-FDJP-CHE110141200 | Expenses - 11-1809-1-KE | |
| 2018-09-30 | Expenditure | EUR 4,306 | CH-FDJP-CHE110141200 | Expenses - 11-1809-1-NL | |
| 2018-09-30 | Expenditure | EUR 13k | CH-FDJP-CHE110141200 | Expenses - 11-1809-1-SD | |
| 2018-10-31 | Expenditure | EUR 442 | CH-FDJP-CHE110141200 | Expenses - 11-1810-1-BR | |
| 2018-10-31 | Expenditure | EUR -147 | CH-FDJP-CHE110141200 | Expenses - 11-1810-1-BR-GB-GOV-1 | |
| 2018-10-31 | Expenditure | EUR 162 | CH-FDJP-CHE110141200 | Expenses - 11-1810-1-CH | |
| 2018-10-31 | Expenditure | EUR 2,542 | CH-FDJP-CHE110141200 | Expenses - 11-1810-1-FR | |
| 2018-10-31 | Expenditure | EUR 56k | CH-FDJP-CHE110141200 | Expenses - 11-1810-1-FR-GB-GOV-1 | |
| 2019-12-31 | Expenditure | EUR 1,675 | CH-FDJP-CHE110141200 | Expenses - 11-1912-1-ZA | |
| 2020-01-31 | Expenditure | EUR 1,388 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-1-BR | |
| 2020-01-31 | Expenditure | EUR -1,482 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-2-BR | |
| 2020-01-31 | Expenditure | EUR -1,308 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-3-BR | |
| 2020-01-31 | Expenditure | EUR -2,096 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-4-BR-GB-GOV-1 | |
| 2020-01-31 | Expenditure | EUR 6,605 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-1-CH | |
| 2020-01-31 | Expenditure | EUR 831 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-2-CH | |
| 2020-01-31 | Expenditure | EUR 2,199 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-3-CH-GB-GOV-1 | |
| 2020-01-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 11-2001-1-KE | |
| 2020-01-31 | Expenditure | EUR 539 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-2-KE | |
| 2020-01-31 | Expenditure | EUR 852 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-3-KE-XM-DAC-7 | |
| 2020-01-31 | Expenditure | EUR 6,356 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-4-KE | |
| 2020-01-31 | Expenditure | EUR 104 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-5-KE-GB-GOV-1 | |
| 2020-01-31 | Expenditure | EUR 186 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-1-MY | |
| 2020-01-31 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 11-2001-1-NL-GB-GOV-1 | |
| 2020-01-31 | Expenditure | EUR 634 | Drugs for Neglected Diseases initiative | Expenses - 11-2001-1-US | |
| 2020-01-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 11-2001-1-ZA | |
| 2020-02-29 | Expenditure | EUR 934 | Drugs for Neglected Diseases initiative | Expenses - 11-2002-1-BR | |
| 2020-02-29 | Expenditure | EUR 24 | Drugs for Neglected Diseases initiative | Expenses - 11-2002-2-BR | |
| 2020-02-29 | Expenditure | EUR 496 | Drugs for Neglected Diseases initiative | Expenses - 11-2002-3-BR | |
| 2020-02-29 | Expenditure | EUR 1,149 | Drugs for Neglected Diseases initiative | Expenses - 11-2002-1-CH | |
| 2020-02-29 | Expenditure | EUR 1,025 | Drugs for Neglected Diseases initiative | Expenses - 11-2002-2-CH | |
| 2020-02-29 | Expenditure | EUR 4,506 | Drugs for Neglected Diseases initiative | Expenses - 11-2002-1-GB | |
| 2020-02-29 | Expenditure | EUR 23k | Drugs for Neglected Diseases initiative | Expenses - 11-2002-1-KE | |
| 2020-02-29 | Expenditure | EUR 2,178 | Drugs for Neglected Diseases initiative | Expenses - 11-2002-2-KE | |
| 2020-02-29 | Expenditure | EUR 210 | Drugs for Neglected Diseases initiative | Expenses - 11-2002-1-MY | |
| 2020-02-29 | Expenditure | EUR 1,059 | Drugs for Neglected Diseases initiative | Expenses - 11-2002-1-US | |
| 2020-02-29 | Expenditure | EUR 25k | Drugs for Neglected Diseases initiative | Expenses - 11-2002-1-ZA | |
| 2020-03-31 | Expenditure | EUR 968 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-1-BR | |
| 2020-03-31 | Expenditure | EUR 0 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-2-BR | |
| 2020-03-31 | Expenditure | EUR 832 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-3-BR | |
| 2020-03-31 | Expenditure | EUR 1,025 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-1-CH | |
| 2020-03-31 | Expenditure | EUR 3,194 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-1-FR | |
| 2020-03-31 | Expenditure | EUR 1,402 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-1-GB-XM-DAC-7 | |
| 2020-03-31 | Expenditure | EUR 8,742 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-1-KE | |
| 2020-03-31 | Expenditure | EUR 23 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-2-KE | |
| 2020-03-31 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses - 11-2003-3-KE-GB-GOV-1 | |
| 2020-03-31 | Expenditure | EUR 384 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-1-MY | |
| 2020-03-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 11-2003-1-NL | |
| 2020-03-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 11-2003-2-NL-XM-DAC-7 | |
| 2020-03-31 | Expenditure | EUR 9,263 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-3-NL-GB-GOV-1 | |
| 2020-03-31 | Expenditure | EUR 880 | Drugs for Neglected Diseases initiative | Expenses - 11-2003-1-SD | |
| 2020-03-31 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses - 11-2003-1-ZA | |
| 2020-04-30 | Expenditure | EUR 1,340 | Drugs for Neglected Diseases initiative | Expenses - 11-2004-1-BR | |
| 2020-04-30 | Expenditure | EUR 326 | Drugs for Neglected Diseases initiative | Expenses - 11-2004-2-BR-GB-GOV-1 | |
| 2019-02-28 | Expenditure | EUR 233 | CH-FDJP-CHE110141200 | Expenses - 11-1902-1-BR | |
| 2019-02-28 | Expenditure | EUR 59 | CH-FDJP-CHE110141200 | Expenses - 11-1902-1-BR-GB-GOV-1 | |
| 2019-02-28 | Expenditure | EUR 3,646 | CH-FDJP-CHE110141200 | Expenses - 11-1902-1-CH | |
| 2019-02-28 | Expenditure | EUR 3,286 | CH-FDJP-CHE110141200 | Expenses - 11-1902-1-CH-GB-GOV-1 | |
| 2019-02-28 | Expenditure | EUR 39k | CH-FDJP-CHE110141200 | Expenses - 11-1902-1-KE | |
| 2019-02-28 | Expenditure | EUR 8,775 | CH-FDJP-CHE110141200 | Expenses - 11-1902-1-NL | |
| 2019-03-31 | Expenditure | EUR 181 | CH-FDJP-CHE110141200 | Expenses - 11-1903-1-BR | |
| 2019-03-31 | Expenditure | EUR -28 | CH-FDJP-CHE110141200 | Expenses - 11-1903-1-BR-GB-GOV-1 | |
| 2019-03-31 | Expenditure | EUR 0 | CH-FDJP-CHE110141200 | Expenses - 11-1903-1-CD | |
| 2019-03-31 | Expenditure | EUR 2,227 | CH-FDJP-CHE110141200 | Expenses - 11-1903-1-CH | |
| 2019-03-31 | Expenditure | EUR 3,874 | CH-FDJP-CHE110141200 | Expenses - 11-1903-1-CH-GB-GOV-1 | |
| 2019-03-31 | Expenditure | EUR 1,118 | CH-FDJP-CHE110141200 | Expenses - 11-1903-1-FR | |
| 2019-03-31 | Expenditure | EUR 26k | CH-FDJP-CHE110141200 | Expenses - 11-1903-1-KE | |
| 2019-03-31 | Expenditure | EUR 11k | CH-FDJP-CHE110141200 | Expenses - 11-1903-1-NL | |
| 2019-04-30 | Expenditure | EUR 640 | CH-FDJP-CHE110141200 | Expenses - 11-1904-1-BR | |
| 2019-04-30 | Expenditure | EUR 6,314 | CH-FDJP-CHE110141200 | Expenses - 11-1904-1-CH | |
| 2019-04-30 | Expenditure | EUR 656 | CH-FDJP-CHE110141200 | Expenses - 11-1904-1-FR | |
| 2019-04-30 | Expenditure | EUR 2,879 | CH-FDJP-CHE110141200 | Expenses - 11-1904-1-GB | |
| 2019-04-30 | Expenditure | EUR 29k | CH-FDJP-CHE110141200 | Expenses - 11-1904-1-KE | |
| 2019-04-30 | Expenditure | EUR 1,872 | CH-FDJP-CHE110141200 | Expenses - 11-1904-1-KE-GB-GOV-1 | |
| 2019-04-30 | Expenditure | EUR 7,881 | CH-FDJP-CHE110141200 | Expenses - 11-1904-1-NL | |
| 2019-04-30 | Expenditure | EUR 1,200 | CH-FDJP-CHE110141200 | Expenses - 11-1904-1-US | |
| 2019-05-31 | Expenditure | EUR 1,433 | CH-FDJP-CHE110141200 | Expenses - 11-1905-1-BR | |
| 2019-05-31 | Expenditure | EUR 7,711 | CH-FDJP-CHE110141200 | Expenses - 11-1905-1-CH | |
| 2019-05-31 | Expenditure | EUR 25k | CH-FDJP-CHE110141200 | Expenses - 11-1905-1-KE | |
| 2019-05-31 | Expenditure | EUR 11k | CH-FDJP-CHE110141200 | Expenses - 11-1905-1-NL | |
| 2019-05-31 | Expenditure | EUR 6,170 | CH-FDJP-CHE110141200 | Expenses - 11-1905-1-ZA | |
| 2019-05-31 | Expenditure | EUR 4,930 | CH-FDJP-CHE110141200 | Expenses - 11-1905-2-KE-GB-GOV-1 | |
| 2019-06-30 | Expenditure | EUR 1,050 | CH-FDJP-CHE110141200 | Expenses - 11-1906-1-BE | |
| 2019-06-30 | Expenditure | EUR 1,068 | CH-FDJP-CHE110141200 | Expenses - 11-1906-1-BR | |
| 2019-06-30 | Expenditure | EUR 6,079 | CH-FDJP-CHE110141200 | Expenses - 11-1906-1-CH | |
| 2019-06-30 | Expenditure | EUR 4,703 | CH-FDJP-CHE110141200 | Expenses - 11-1906-1-FR-GB-GOV-1 | |
| 2019-06-30 | Expenditure | EUR 3,488 | CH-FDJP-CHE110141200 | Expenses - 11-1906-1-GB | |
| 2019-06-30 | Expenditure | EUR 15k | CH-FDJP-CHE110141200 | Expenses - 11-1906-1-KE | |
| 2019-06-30 | Expenditure | EUR 6,977 | CH-FDJP-CHE110141200 | Expenses - 11-1906-1-NL | |
| 2019-06-30 | Expenditure | EUR 64 | CH-FDJP-CHE110141200 | Expenses - 11-1906-1-US | |
| 2019-07-31 | Expenditure | EUR 1,129 | CH-FDJP-CHE110141200 | Expenses - 11-1907-1-BR | |
| 2019-07-31 | Expenditure | EUR 4,356 | CH-FDJP-CHE110141200 | Expenses - 11-1907-1-CH | |
| 2019-07-31 | Expenditure | EUR 2,337 | CH-FDJP-CHE110141200 | Expenses - 11-1907-1-GB | |
| 2019-07-31 | Expenditure | EUR 19k | CH-FDJP-CHE110141200 | Expenses - 11-1907-1-KE | |
| 2019-07-31 | Expenditure | EUR 6,013 | CH-FDJP-CHE110141200 | Expenses - 11-1907-1-NL | |
| 2019-08-31 | Expenditure | EUR 327 | CH-FDJP-CHE110141200 | Expenses - 11-1908-1-BR | |
| 2019-08-31 | Expenditure | EUR 5,116 | CH-FDJP-CHE110141200 | Expenses - 11-1908-1-CH | |
| 2019-08-31 | Expenditure | EUR 1,752 | CH-FDJP-CHE110141200 | Expenses - 11-1908-1-GB | |
| 2019-08-31 | Expenditure | EUR 18k | CH-FDJP-CHE110141200 | Expenses - 11-1908-1-KE | |
| 2019-08-31 | Expenditure | EUR 8,694 | CH-FDJP-CHE110141200 | Expenses - 11-1908-1-NL | |
| 2019-09-30 | Expenditure | EUR -448 | CH-FDJP-CHE110141200 | Expenses - 11-1909-1-BR | |
| 2019-09-30 | Expenditure | EUR 6,555 | CH-FDJP-CHE110141200 | Expenses - 11-1909-1-CH | |
| 2019-09-30 | Expenditure | EUR 19k | CH-FDJP-CHE110141200 | Expenses - 11-1909-1-FR | |
| 2019-09-30 | Expenditure | EUR 195 | CH-FDJP-CHE110141200 | Expenses - 11-1909-1-GB | |
| 2019-09-30 | Expenditure | EUR 25k | CH-FDJP-CHE110141200 | Expenses - 11-1909-1-KE | |
| 2020-12-31 | Expenditure | EUR 6,167 | Drugs for Neglected Diseases initiative | Expenses - 11-2012-1-FR-GB-GOV-1 | |
| 2020-12-31 | Expenditure | EUR 30 | Drugs for Neglected Diseases initiative | Expenses - 11-2012-1-KE | |
| 2020-12-31 | Expenditure | EUR 39k | Drugs for Neglected Diseases initiative | Expenses - 11-2012-2-KE | |
| 2020-12-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 11-2012-3-KE-GB-GOV-1 | |
| 2020-12-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 11-2012-1-NL-GB-GOV-1 | |
| 2020-12-31 | Expenditure | EUR 382 | Drugs for Neglected Diseases initiative | Expenses - 11-2012-1-SD-GB-GOV-1 | |
| 2020-06-30 | Expenditure | EUR 745 | Drugs for Neglected Diseases initiative | Expenses - 11-2006-1-US | |
| 2020-07-31 | Expenditure | EUR 97 | Drugs for Neglected Diseases initiative | Expenses - 11-2007-1-BR | |
| 2020-07-31 | Expenditure | EUR 783 | Drugs for Neglected Diseases initiative | Expenses - 11-2007-2-BR | |
| 2020-07-31 | Expenditure | EUR 1,024 | Drugs for Neglected Diseases initiative | Expenses - 11-2007-1-CH-GB-GOV-1 | |
| 2020-07-31 | Expenditure | EUR 702 | Drugs for Neglected Diseases initiative | Expenses - 11-2007-1-KE | |
| 2020-07-31 | Expenditure | EUR 21k | Drugs for Neglected Diseases initiative | Expenses - 11-2007-2-KE | |
| 2020-07-31 | Expenditure | EUR 702 | Drugs for Neglected Diseases initiative | Expenses - 11-2007-3-KE-GB-GOV-1 | |
| 2020-07-31 | Expenditure | EUR 165 | Drugs for Neglected Diseases initiative | Expenses - 11-2007-1-MY | |
| 2020-07-31 | Expenditure | EUR 8,856 | Drugs for Neglected Diseases initiative | Expenses - 11-2007-1-NL | |
| 2020-07-31 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 11-2007-2-NL-XM-DAC-7 | |
| 2020-07-31 | Expenditure | EUR 1,423 | Drugs for Neglected Diseases initiative | Expenses - 11-2007-1-ZA-XM-DAC-7 | |
| 2020-08-31 | Expenditure | EUR 1,013 | Drugs for Neglected Diseases initiative | Expenses - 11-2008-1-BR | |
| 2020-08-31 | Expenditure | EUR 366 | Drugs for Neglected Diseases initiative | Expenses - 11-2008-1-CH | |
| 2020-08-31 | Expenditure | EUR 1,025 | Drugs for Neglected Diseases initiative | Expenses - 11-2008-2-CH-GB-GOV-1 | |
| 2020-08-31 | Expenditure | EUR 544 | Drugs for Neglected Diseases initiative | Expenses - 11-2008-1-KE | |
| 2020-08-31 | Expenditure | EUR 7,887 | Drugs for Neglected Diseases initiative | Expenses - 11-2008-2-KE | |
| 2020-08-31 | Expenditure | EUR 4,645 | Drugs for Neglected Diseases initiative | Expenses - 11-2008-3-KE-XM-DAC-7 | |
| 2020-08-31 | Expenditure | EUR 2,146 | Drugs for Neglected Diseases initiative | Expenses - 11-2008-4-KE-GB-GOV-1 | |
| 2020-08-31 | Expenditure | EUR 653 | Drugs for Neglected Diseases initiative | Expenses - 11-2008-5-KE | |
| 2020-08-31 | Expenditure | EUR 161 | Drugs for Neglected Diseases initiative | Expenses - 11-2008-1-MY | |
| 2020-08-31 | Expenditure | EUR 9,019 | Drugs for Neglected Diseases initiative | Expenses - 11-2008-1-NL | |
| 2020-08-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 11-2008-1-SD | |
| 2020-09-30 | Expenditure | EUR 1 | Drugs for Neglected Diseases initiative | Expenses - 11-2009-1-BR | |
| 2020-09-30 | Expenditure | EUR 709 | Drugs for Neglected Diseases initiative | Expenses - 11-2009-2-BR-GB-GOV-1 | |
| 2020-09-30 | Expenditure | EUR 191 | Drugs for Neglected Diseases initiative | Expenses - 11-2009-1-CH-XM-DAC-7 | |
| 2020-09-30 | Expenditure | EUR 833 | Drugs for Neglected Diseases initiative | Expenses - 11-2009-2-CH | |
| 2020-09-30 | Expenditure | EUR 2,490 | Drugs for Neglected Diseases initiative | Expenses - 11-2009-1-FR-GB-GOV-1 | |
| 2020-04-30 | Expenditure | EUR 1,025 | Drugs for Neglected Diseases initiative | Expenses - 11-2004-1-CH-GB-GOV-1 | |
| 2020-04-30 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 11-2004-1-GB | |
| 2020-04-30 | Expenditure | EUR 29k | Drugs for Neglected Diseases initiative | Expenses - 11-2004-1-KE | |
| 2020-04-30 | Expenditure | EUR 4,447 | Drugs for Neglected Diseases initiative | Expenses - 11-2004-2-KE | |
| 2020-04-30 | Expenditure | EUR 612 | Drugs for Neglected Diseases initiative | Expenses - 11-2004-3-KE-GB-GOV-1 | |
| 2020-04-30 | Expenditure | EUR -0 | Drugs for Neglected Diseases initiative | Expenses - 11-2004-4-KE | |
| 2020-04-30 | Expenditure | EUR 233 | Drugs for Neglected Diseases initiative | Expenses - 11-2004-1-MY | |
| 2020-04-30 | Expenditure | EUR 1,204 | Drugs for Neglected Diseases initiative | Expenses - 11-2004-1-US | |
| 2020-04-30 | Expenditure | EUR 49k | Drugs for Neglected Diseases initiative | Expenses - 11-2004-1-ZA | |
| 2020-05-31 | Expenditure | EUR 706 | Drugs for Neglected Diseases initiative | Expenses - 11-2005-1-BR | |
| 2020-05-31 | Expenditure | EUR 693 | Drugs for Neglected Diseases initiative | Expenses - 11-2005-2-BR | |
| 2020-05-31 | Expenditure | EUR 1,025 | Drugs for Neglected Diseases initiative | Expenses - 11-2005-1-CH | |
| 2020-05-31 | Expenditure | EUR 1,461 | Drugs for Neglected Diseases initiative | Expenses - 11-2005-1-FR | |
| 2020-05-31 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 11-2005-1-KE | |
| 2020-05-31 | Expenditure | EUR 3,141 | Drugs for Neglected Diseases initiative | Expenses - 11-2005-2-KE | |
| 2020-05-31 | Expenditure | EUR 201 | Drugs for Neglected Diseases initiative | Expenses - 11-2005-1-MY | |
| 2020-05-31 | Expenditure | EUR 9,247 | Drugs for Neglected Diseases initiative | Expenses - 11-2005-1-NL | |
| 2020-05-31 | Expenditure | EUR 9,344 | Drugs for Neglected Diseases initiative | Expenses - 11-2005-2-NL | |
| 2020-05-31 | Expenditure | EUR 617 | Drugs for Neglected Diseases initiative | Expenses - 11-2005-1-US | |
| 2020-06-30 | Expenditure | EUR 614 | Drugs for Neglected Diseases initiative | Expenses - 11-2006-1-BR | |
| 2020-06-30 | Expenditure | EUR 1,025 | Drugs for Neglected Diseases initiative | Expenses - 11-2006-1-CH-GB-GOV-1 | |
| 2020-06-30 | Expenditure | EUR 966 | Drugs for Neglected Diseases initiative | Expenses - 11-2006-1-FR | |
| 2020-06-30 | Expenditure | EUR 3,485 | Drugs for Neglected Diseases initiative | Expenses - 11-2006-1-KE | |
| 2019-09-30 | Expenditure | EUR 5,281 | CH-FDJP-CHE110141200 | Expenses - 11-1909-1-NL | |
| 2019-10-31 | Expenditure | EUR 71 | CH-FDJP-CHE110141200 | Expenses - 11-1910-1-BR | |
| 2019-10-31 | Expenditure | EUR 6,331 | CH-FDJP-CHE110141200 | Expenses - 11-1910-1-CH | |
| 2019-10-31 | Expenditure | EUR 2,061 | CH-FDJP-CHE110141200 | Expenses - 11-1910-1-GB | |
| 2019-10-31 | Expenditure | EUR 16k | CH-FDJP-CHE110141200 | Expenses - 11-1910-1-KE | |
| 2019-10-31 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 11-1910-1-NL | |
| 2019-10-31 | Expenditure | EUR 682 | CH-FDJP-CHE110141200 | Expenses - 11-1910-1-US | |
| 2019-10-31 | Expenditure | EUR 43k | CH-FDJP-CHE110141200 | Expenses - 11-1910-1-ZA | |
| 2019-11-30 | Expenditure | EUR 1,472 | CH-FDJP-CHE110141200 | Expenses - 11-1911-1-BR | |
| 2019-11-30 | Expenditure | EUR 6,210 | CH-FDJP-CHE110141200 | Expenses - 11-1911-1-CH | |
| 2019-11-30 | Expenditure | EUR 56k | CH-FDJP-CHE110141200 | Expenses - 11-1911-1-KE | |
| 2019-11-30 | Expenditure | EUR 9,647 | CH-FDJP-CHE110141200 | Expenses - 11-1911-1-NL | |
| 2019-12-31 | Expenditure | EUR 813 | CH-FDJP-CHE110141200 | Expenses - 11-1912-1-BR | |
| 2019-12-31 | Expenditure | EUR 15k | CH-FDJP-CHE110141200 | Expenses - 11-1912-1-CH | |
| 2019-12-31 | Expenditure | EUR 31k | CH-FDJP-CHE110141200 | Expenses - 11-1912-1-FR | |
| 2019-12-31 | Expenditure | EUR 5,931 | CH-FDJP-CHE110141200 | Expenses - 11-1912-1-GB | |
| 2019-12-31 | Expenditure | EUR 83 | CH-FDJP-CHE110141200 | Expenses - 11-1912-1-IN | |
| 2019-12-31 | Expenditure | EUR 71k | CH-FDJP-CHE110141200 | Expenses - 11-1912-1-KE | |
| 2019-12-31 | Expenditure | EUR 302 | CH-FDJP-CHE110141200 | Expenses - 11-1912-1-MY | |
| 2019-12-31 | Expenditure | EUR 44k | CH-FDJP-CHE110141200 | Expenses - 11-1912-1-NL | |
| 2019-12-31 | Expenditure | EUR 4,480 | CH-FDJP-CHE110141200 | Expenses - 11-1912-1-US | |
| 2023-01-31 | Expenditure | EUR -2,370 | Drugs for Neglected Diseases initiative | Expenses - 11-2301-1-BR | |
| 2020-06-30 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 11-2006-2-KE | |
| 2020-06-30 | Expenditure | EUR 393 | Drugs for Neglected Diseases initiative | Expenses - 11-2006-3-KE-XM-DAC-7 | |
| 2020-06-30 | Expenditure | EUR 166 | Drugs for Neglected Diseases initiative | Expenses - 11-2006-1-MY | |
| 2021-01-31 | Expenditure | EUR -550 | Drugs for Neglected Diseases initiative | Expenses - 11-2101-1-BR | |
| 2021-01-31 | Expenditure | EUR -1,167 | Drugs for Neglected Diseases initiative | Expenses - 11-2101-2-BR | |
| 2021-01-31 | Expenditure | EUR 41 | Drugs for Neglected Diseases initiative | Expenses - 11-2101-3-BR-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 1,024 | Drugs for Neglected Diseases initiative | Expenses - 11-2101-1-CH | |
| 2021-01-31 | Expenditure | EUR 1,280 | Drugs for Neglected Diseases initiative | Expenses - 11-2101-2-CH-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 5,004 | Drugs for Neglected Diseases initiative | Expenses - 11-2101-1-KE | |
| 2021-01-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 11-2101-2-KE | |
| 2021-01-31 | Expenditure | EUR 68 | Drugs for Neglected Diseases initiative | Expenses - 11-2101-3-KE-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 79 | Drugs for Neglected Diseases initiative | Expenses - 11-2101-1-US | |
| 2021-01-31 | Expenditure | EUR 664 | Drugs for Neglected Diseases initiative | Expenses - 11-2101-2-US-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 331 | Drugs for Neglected Diseases initiative | Expenses - 11-2102-1-BR | |
| 2021-02-28 | Expenditure | EUR 3,098 | Drugs for Neglected Diseases initiative | Expenses - 11-2102-1-CH |
Showing 300 of 791. The API returns all of them.
Struck-through rows were in the previous version, last seen 2026-10-02 02:19 UTC, and are not in the current file.